158 related articles for article (PubMed ID: 35325798)
1. Quantification of the irreversible fibroblast growth factor receptor inhibitor futibatinib by UPLC-MS/MS: Application to the metabolic stability assay in human liver microsomes for the estimation of its in vitro hepatic intrinsic clearance.
Tang LWT; Chan ECY
J Pharm Biomed Anal; 2022 May; 214():114731. PubMed ID: 35325798
[TBL] [Abstract][Full Text] [Related]
2. An ultra-high performance liquid chromatography-tandem mass spectrometric assay for quantifying 3-ketocholanoic acid: Application to the human liver microsomal CYP3A-dependent lithocholic acid 3-oxidation assay.
Bansal S; Chai SF; Lau AJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():1-8. PubMed ID: 27153105
[TBL] [Abstract][Full Text] [Related]
3. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
[TBL] [Abstract][Full Text] [Related]
4. A novel bioanalytical method for the quantification of pemigatinib in rat plasma by UPLC-MS/MS.
Weng Q; Tan W; Yu RY; Xu RA; Chen Y
J Pharm Biomed Anal; 2021 Aug; 202():114137. PubMed ID: 34015593
[TBL] [Abstract][Full Text] [Related]
5. Fast and sensitive quantification of human liver cytosolic lithocholic acid sulfation using ultra-high performance liquid chromatography-tandem mass spectrometry.
Bansal S; Lau AJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():171-8. PubMed ID: 26773894
[TBL] [Abstract][Full Text] [Related]
6. UPLC-MS/MS assay of 21-aminosteroid (lazaroid U74389G) for application in pharmacokinetic study.
Gadgil P; Ibrahim F; Chow DS
J Pharm Biomed Anal; 2016 Apr; 122():90-7. PubMed ID: 26848737
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation.
Attwa MW; Abdelhameed AS; Kadi AA
Drug Des Devel Ther; 2021; 15():3915-3925. PubMed ID: 34552321
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
[TBL] [Abstract][Full Text] [Related]
10. Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation.
Attwa MW; AlRabiah H; Mostafa GAE; Kadi AA
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903565
[TBL] [Abstract][Full Text] [Related]
11. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.
Mostafa GAE; Kadi AA; AlMasoud N; Attwa MW; Al-Shakliah NS; AlRabiah H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122806. PubMed ID: 34325312
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacokinetic and in vitro metabolic stability study of lysosomotropic autophagy inhibitor, IITZ-01 in mice by using UPLC-MS/MS.
Gawali B; Jala A; Gangasani JK; Puppala ER; Borkar RM; Naidu VGM
Anal Biochem; 2023 Dec; 683():115333. PubMed ID: 37907159
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study.
AlRabiah H; Kadi AA; Attwa MW; Mostafa GAE
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1154():122195. PubMed ID: 32943176
[TBL] [Abstract][Full Text] [Related]
14. Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method.
Attwa MW; AlRabiah H; Mostafa GAE; Bakheit AH; Kadi AA
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985590
[TBL] [Abstract][Full Text] [Related]
15. A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study.
Hu X; Xu Y; Chen J; Shen Y; Yang D; Hu Y; Jiang B; Lou H; Ruan Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122954. PubMed ID: 34628186
[TBL] [Abstract][Full Text] [Related]
16. Determination of kurarinone in rat plasma by UPLC-MS/MS.
Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
[TBL] [Abstract][Full Text] [Related]
17. Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation.
Attwa MW; Alanazi MM
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838629
[TBL] [Abstract][Full Text] [Related]
18. A sensitive and rapid bioanalytical method for the quantitative determination of luliconazole in rabbit eye tissues using UPLC-MS/MS assay.
Yang J; Liang Z; Lu P; Song F; Zhang Z; Xia H; He J; Zhou T; Zhang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123173. PubMed ID: 35219088
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel and quick UPLC-MS/MS method for the pharmacokinetic analysis of duvelisib in beagle dogs.
Shao Y; Xie S; Zhu H; Du X; Xu RA
J Pharm Biomed Anal; 2020 Aug; 187():113355. PubMed ID: 32442869
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a rapid and sensitive UPLC-MS/MS assay for the quantification of tofacitinib in human plasma.
Bharwad KD; Shah PA; Shrivastav PS; Singhal P
Biomed Chromatogr; 2019 Apr; 33(4):e4458. PubMed ID: 30520053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
